Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Ultragenyx Pharmaceutical (NASDAQ:RARE) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
- Period
- Q3 2026 earnings call
- Date
- Tue, Nov 3, 2026, 5:00 PM ET
On 6ix: 6ix.com/event/ultragenyx-pharmaceutical-inc-rare-q3-2026-earnings-call
Latest news releases
- NASDAQ:RARE — Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update · Tue, Oct 27, 2026
- NASDAQ:RARE — Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million · Wed, Oct 14, 2026